Table 1.
Study characteristics
| Author (year) | Study type | Patients included(n analyzed) | Patients evaluated (n [% male]) | Follow‐up duration(months) | |
|---|---|---|---|---|---|
| T | C | ||||
| Acute myocardial infarction | |||||
| Chen (2004) (China) | RCT | 69 | 34 (94) | 35 (97) | 6 |
| Chullikana (2015) (India) | RCT | 20 (safety) 19 (efficacy) |
10 (100) | 10 (80) | 24 |
| Gao (2013) (China) | RCT | 43 | 21 (100) | 22 (86) | 24 |
| Gao (2015) (China) | RCT | 115 | 58 (95) | 58 (88) | 18 |
| Hare (2009) (USA) | RCT | 53 | 34 (82) | 19 (79) | 6 |
| Houtgraaf (2012) (Netherlands) | RCT | 13 | 9 (69) | 4 (31) | 6 |
| Lee (2014) (South Korea) | RCT | 58 | 30 (90) | 28 (89) | 6 |
| Musialek (2015) (Poland) | Single‐arm | 10 | 10 (50) | 12 | |
| Rodrigo (2013) (Netherlands) | Historical control | 54 | 9 (78) | 45 (78) | 60 |
| Wang (2014) (China) | RCT | 58 | 28 (68) | 30 (53) | 6 |
| Yang (2010) (China) | Single‐arm | 16 | 16 (NR) | 6 | |
| Ischemic heart failure | |||||
| Bartunek (2017) (Belgium) | RCT | 271 | 107 (89) | 136 (90) | 10 |
| Chen (2006) (China) | NRCT | 45 | 22 (88) | 23 (92) | 12 |
| Guijarro (2016) (France) | Single‐arm | 10 | 10 (90) | 12 | |
| Hare (2012) (USA) | Non‐controlled | 30 | 15 (87) | 15 (87) | 13 |
| Heldman (2014) (USA) | RCT | 59 | 19 (95) | 11 (91) | 12 |
| Karantalis (2014) (USA) | Single‐arm | 6 | 6 (100) | 18 | |
| Li (2015) (China) | Single‐arm | 15 | 15 (60) | 24 | |
| Mathiasen (2013) (Denmark) | Single‐arm | 31 | 31 (84) | 36 | |
| Mathiasen (2015) (Denmark) | RCT | 59 | 40 (90) | 20 (70) | 6 |
| Viswanathan (2010) (India) | NRCT | 30 | 15 (100) | 15 (93) | 6 |
| Wang (2006) (China) | RCT | 24 | 12 (75) | 12 (67) | 10 |
| Zhao (2015) (China) | RCT | 59 | 30 (80) | 29 (66) | 6 |
Abbreviations: C, control group; NR, not reported; NRCT, non‐randomized controlled trial; RCT, randomized controlled trial; T, treatment group.